<DOC>
<DOCNO>
EP-0013783
</DOCNO>
<TEXT>
<DATE>
19800806
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/19 <main>A61K-31/70</main> A61K-31/185 A61K-31/70 A61K-31/60 
</IPC-CLASSIFICATIONS>
<TITLE>
protection of the gastric mucosal lining from damage by aspirin and related drugs.
</TITLE>
<APPLICANT>
univ australianau<sep>the australian national university<sep>the australian national universityacton, australian capital territory 2600au<sep>the australian national university <sep>
</APPLICANT>
<INVENTOR>
rainsford kim drummond dr<sep>whitehouse michael wellesley d<sep>rainsford, kim drummond, dr.<sep>whitehouse, michael wellesley, dr.<sep>rainsford, kim drummond, dr.5 binya courtkingston beach tasmania, 7151au<sep>whitehouse, michael wellesley, dr.11 wolgal placearanda act, 2614au<sep>rainsford, kim drummond, dr. <sep>whitehouse, michael wellesley, dr.<sep>rainsford, kim drummond, dr.5 binya courtkingston beach tasmania, 7151au<sep>whitehouse, michael wellesley, dr.11 wolgal placearanda act, 2614au<sep>
</INVENTOR>
<ABSTRACT>
a formulation which allows administration of aspirin  and like drugs and avoids gastrointestinal damage to a sig­ nificant extent is described.  a preferred formulation parti­ cularly useful for protecting the gastric mucosal lining of  arthritic sufferers on a prolonged aspirin medication pro­ gram comprises aspirin, glucose and sodium acetate or so­ dium citrate.  a like composition containing dibromoaspirin  in lieu of aspirin is helpful in reducing gastrointestinal da­ mage to persons suffering from sickle cell disease and  who regularly take dibromoaspirin.  
</ABSTRACT>
</TEXT>
</DOC>
